期刊文献+

错配修复基因hMLH1和hMSH2在胃癌组织中的表达及意义 被引量:3

Mismatch repair gene hMLH1 and hMSH2 expression in gastric cancer tissue and its significance
下载PDF
导出
摘要 目的探讨错配修复基因hMLH1和hMSH2在胃癌发生中的作用。方法采用免疫组化SP法,检测散发性胃癌、癌旁黏膜和胃炎黏膜组织中hMLH1和hMSH2基因的表达情况。结果hMSH2在胃癌组织中的阳性表达率(671%)显著高于癌旁黏膜(414%)和胃炎黏膜组织(412%)(P<005),而后两者无显著差异(P>005)。hMSH2在低分化腺癌中的阳性率(806%)显著高于高中分化腺癌(577%)和黏液癌(538%)(P<005),而后两者无显著差异(P>005)。hMLH1在胃炎黏膜组织的阳性表达率(382%)显著低于胃癌(771%)和癌旁黏膜组织(743%)(P<005),后两者无显著差异(P>005)。hMLH1在黏液癌中的阳性率(385%)显著低于高中分化腺癌(808%)和低分化腺癌(903%)(P<005),后两者无显著差异(P>005)。结论hMSH2高表达可能是胃癌发生的标志之一;hMSH2表达与肿瘤分化程度及患者预后有关;hMLH1有可能作为胃癌预警组织学标记物。 Objective To investigate the role of mismatch repair gene hMLH1 and hMSH2 in carcinogenesis of gastric cancer. Methods The expression of hMLH1 and hMSH2 in sporadic gastric cancer, adjacent mucosa and gastritis mucosa tissue was examined by immunohistochemistry SP method. Results The positive rate of hMSH2 expression in cancer tissue (67.1%) was significantly higher than that in adjacent mucosa (41.4%) and gastritis mucosa tissue (41.2%)(P<0.05); the positive rate in poor differentiated group (80.6%) was significantly higher than those in well differentiated group (57.7%) and mucoid cancer group (53.8%)(P<0.05), but there was no significant difference between the latter two groups (P>0.05). The positive rate of hMLH1 expression (38.2%) was significantly lower than that in gastric cancer (77.1%) and adjacent mucosa tissue (74.3%)(P<0.05); the positive rate in mucoid cancer (38.5%) was significantly lower than those in well (80.8%) and poor differentiated group (90.3%)(P<0.05), but there was no significant difference between the latter two groups (P>0.05). Conclusions The high expression of hMSH2 may be one of potential markers of gastric cancer; the expression of hMSH2 is related to tumor differential degree and prognosis; hMLH1 protein may be a histological marker predicting gastric cancer occurrence.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2005年第2期165-167,共3页 Chinese Journal of Gerontology
基金 中科院知识创新工程领域前沿基金课题(NoDICPkaaaabc)
关键词 胃癌 HMLH1 HMSH2 免疫组织化学 Gastric cancer hMLH1 hMSH2 Immunohistochemistry
  • 相关文献

参考文献13

二级参考文献9

  • 1石一复.子宫颈疾病[M].北京:人民卫生出版社,2001.113-121.
  • 2Jin T X,Cancer,1999年,85卷,2期,478页
  • 3Wei Q,Cancer Epidemiol Biomarkers Prev,1998年,7卷,4期,309页
  • 4Polyak K,Nature Genetics,1998年,20卷,3期,291页
  • 5Wei Q Y,Cancer Res,1997年,57卷,16页
  • 6Mao L,Science,1996年,271卷,659页
  • 7Hamilton S R,New England J Medicine,1995年,332卷,839页
  • 8Cheng N C,Human Mol Genet,1996年,5卷,309页
  • 9马琳,张军航,彭芝兰,曹泽毅.错配修复基因hMSH2蛋白在人卵巢恶性肿瘤组织中的表达及其临床意义[J].中华妇产科杂志,2000,35(5):291-293. 被引量:12

共引文献33

同被引文献25

  • 1张天华,邹小明,刘建丰,曹守强.MGMT蛋白在胃癌中的表达及其临床意义[J].中国普通外科杂志,2005,14(3):225-227. 被引量:13
  • 2梁刚,钟德玝,杨竹林,邓星辉.MGMT在原发性肝癌中的表达及其临床意义[J].中国现代医学杂志,2005,15(7):1009-1011. 被引量:4
  • 3宋伟庆,韩彩丽,周保军,于世杰,张占学.胃癌中微卫星不稳定性与错配修复酶的研究[J].中华实验外科杂志,2005,22(11):1408-1408. 被引量:4
  • 4吴迎爽,周宁,程毅,魏贵亮,谢震,祁贺,薄爱华,张晓丽,邢立强.DNA修复酶在胃癌组织中的表达变化及临床意义[J].河北北方学院学报(医学版),2005,22(5):15-17. 被引量:2
  • 5罗守颖.胃癌病例对照研究[J].中国社区医学,2005,11(4):4-4. 被引量:1
  • 6Wu CW,Chen GD,Jiang KC,et al.A genome-wide study of microsatellite instability in advanced gastric carcinoma[J].Cancer 2001,92:92-101.
  • 7Chiaravalli AM,Furlan D,Facco C,et al.Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal,gastric,endometrial and ovarian carcinomas with instability in microsalcllite sequences[J].Virchows Arch,2001,438(1):39-48.
  • 8Kitajima Y,Miyazaki K,Matsukura S,et al.Loss of expression of DNA repair enzymes MGMT,hMLH1,and hMSH2 during tumor progression in gastric cancer[J].Gastric Cancer,2003,6(2):86-95.
  • 9Drotschmann K,Clark AB,Kunkel TA,et al.Mutator phenotypes of common polymorphisms and missense mutations in MSH2[J].Curr Biol,1999,9(16):907-910.
  • 10Peim G,Diebold J,Mayr D,et al.Prognostic relevance of hMLH1,hMSH2,and BAX protein expression in endometrial carcinoma[J].MolePathol,2001,14(8):77-83.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部